1. Andrews RC, Andersen MW, Stanford JB, Bubacz DG, Chan JH, Cowan DJ, Gaul MD, McDougald DL, Musso DL, Rabinowitz, MH, Wiethe, RW (1998) Preparation of peptidyl reverse hydroxamate derivatives as metalloprotease inhibitors. PCT Int Appl WO 9838179.
2. Bailey S, Bolognese B, Buckle DR, Faller A, Jackson S, Louis-Flamberg P, McCord M, Mayer RJ, Marshall LA, Smith DG (1998). Selective inhibition of low affinity IgE receptor (CD23) processing. Bioorg Med Chem Lett 8:29–34.
3. Barberia JT, Sweeney FJ, Carty TJ (1996) Development of a cell — based assay for TNF-α release which avoids transcription and translation steps. Poster Presentation, Fifth International Conference, Inflammation Research Association, October 1996. Hershey, PA, USA. Abstract P1.
4. Beckett RP, Whittaker M (1998) Matrix metalloproteinase inhibitors. Expert Opin Ther Pat 8:259–282.
5. Beckett RP, Davidson AH, Drummond AH, Huxley P, Whittaker M (1996) Recent advances in matrix metalloproteinase inhibitor research. Drug Discovery Today 1:16–26.